Cart
sales@molnova.com
Nef-IN-B9
CAS No. 1473404-51-1
Nef-IN-B9 ( Nef inhibitor B9 )
Catalog No. M12024 CAS No. 1473404-51-1
Nef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 170 | Get Quote |
|
| 5MG | 260 | Get Quote |
|
| 10MG | 408 | Get Quote |
|
| 25MG | 672 | Get Quote |
|
| 50MG | 945 | Get Quote |
|
| 100MG | 1278 | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameNef-IN-B9
-
NoteResearch use only, not for human use.
-
Brief DescriptionNef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM.
-
DescriptionNef-IN-B9 (Nef inhibitor B9) is a small molecule that blocks Nef-dependent Hck activity with IC50 of 2.8 uM, while the activity against Hck alone is >20 uM; also showes weak activity against other Src-family members with IC50 of >20 uM for c-Src, Lck and Lyn; blocks wild-type HIV-1 replication with IC50 of 100-300 nM, and blocks Nef-mediated SFK activation in HIV-infected cells; binds directly to Nef with Kd of 1.79 nM.
-
SynonymsNef inhibitor B9
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorHIV
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1473404-51-1
-
Formula Weight402.81
-
Molecular FormulaC16H11ClN6O3S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(E)-4-((3-chlorophenyl)diazenyl)-5-hydroxy-3-(4-nitrophenyl)-1H-pyrazole-1-carbothioamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Emert-Sedlak LA, et al. Chem Biol. 2013 Jan 24;20(1):82-91.
molnova catalog
related products
-
Nelfinavir
A potent and orally bioavailable HIV-1 protease inhibitor with Ki of 2 nM.
-
Raltegravir
A potent, selective, orally bioavailable HIV-integrase inhibitor with IC50 of 15 nM.
-
Peptide T
Peptide T is an octapeptide from the V2 region of HIV-1 gp120. Peptide T is a synthetic octapeptide whose possible mechanism of action is the competitive inhibition of gp120 to the CD4 receptor as well as binding to vasointestinal peptide receptors and inhibiting cytokine action.
